Domestic Manufacturers Aim to Realize Faster Market Share Gains for First Generics

Published: 2005-02-11 06:59:00

Updated: 2005-02-11 06:59:00

The domestic pharmaceutical firms are increasing their efforts to gain the first-hand competitive advantages by executing faster introductions of the first generic products in the market.

The firms collectively make strategic observations on the original drugs and their expected patent and pos...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK